Jeffrey Barrett
Chief Tech/Sci/R&D Officer at NIGHTINGALE HEALTH OYJ
Net worth: 9 394 $ as of 2024-03-30
Profile
Jeffrey Barrett is currently the Chief Scientific Officer at Nightingale Health Oyj since 2021.
Prior to this, he worked as the Director and Chief Scientific Officer at Genomics Plc.
He obtained a doctorate degree from the University of Oxford.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-06-29 | 8,364 ( 0.02% ) | 9 394 $ | 2024-03-30 |
Jeffrey Barrett active positions
| Companies | Position | Start |
|---|---|---|
| NIGHTINGALE HEALTH OYJ | Chief Tech/Sci/R&D Officer | 2021-09-26 |
Former positions of Jeffrey Barrett
| Companies | Position | End |
|---|---|---|
Genomics Plc
 Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Chief Tech/Sci/R&D Officer | - |
Training of Jeffrey Barrett
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NIGHTINGALE HEALTH OYJ | Commercial Services |
| Private companies | 1 |
|---|---|
Genomics Plc
Genomics Plc BiotechnologyHealth Technology Genomics Plc develops research and experimental development on biotechnology. It develops and applies cutting edge analysis and algorithms to database of genomic and phenotypic data to uncover the relationships between genetic variation and human disease. The company was founded by Peter Donnely, Gil McVean, Chris Spencer and Gerton Lunter on January 10, 2004 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jeffrey Barrett
